Skip to content
AlternativeMed

Ethnopharmacology: From Folk Use to Drug Discovery

How traditional plant use has led researchers to new medicines, why the step from folk use to a proven drug is long, and why a lab finding on a herb is not the same as a treatment.

Content last updated . This page has not been medically reviewed.

What ethnopharmacology is

Ethnopharmacology is the study of traditionally used natural products and their biological activity. [1] Researchers read records of traditional use, test the plants in the laboratory, isolate active compounds, and then, if a compound looks promising, test it in animals and people. The step from folk use to a medicine is long and most leads do not make it. This page describes what has happened, with careful framing. The records come from ethnobotany; see how plant knowledge is recorded.

Traditional use as a starting point

A review of ethnopharmacology and drug discovery says that descriptions of the use of natural products in traditional medicine have served as starting points for new therapeutics. [2] The same authors say that details such as traditional harvest, preparation, storage and administration can give valuable information about the active compounds. [2]

Natural products more broadly matter to medicine. A long-running review of drugs approved from 1981 to 2019 found that the influence of natural product structures is quite marked, with the anti-infective area especially dependent on them. [3] That review counts natural products and their derivatives, not only those with a traditional use history.

Worked example: artemisinin

The Nobel Prize committee describes how Tu Youyou in China turned to traditional herbal medicine to tackle the challenge of developing novel malaria therapies. [4] An extract of Artemisia annua emerged as an interesting candidate. [4] Results were inconsistent, so she revisited the older literature, found clues that guided her, and went on to show that the purified component, artemisinin, was highly effective against the malaria parasite. [4]

The lesson is about method. The tradition suggested where to look. The proof came from isolating the compound and testing it. A tea made from the plant is not the same product as the purified drug. For more, see drugs with traditional origins.

Why most leads do not become treatments

Reviewers of ethnobotany-guided discovery note that there has been a sharp decline in the ability to translate laboratory research into successful clinical programs. [1] Evidence labels help here:
StageWhat it showsLabel
Traditional recordPeople use the plant for a purposeTraditional use only
Laboratory or animal testA compound has activity in cells or animalsPreclinical
Small human studyPossible effect and safety signalsPromising but limited
Well-run trials, repeatedEffect against comparison treatmentEstablished if consistent

A headline saying a herb "kills cancer cells in a dish" is preclinical. It is not a treatment, and it is not advice to take the herb.

Example: from folk use to a product, with limits

Pelargonium sidoides is described as one of several tuberous Pelargonium species that are important traditional medicines with a rich ethnobotanical history, and the review credits convincing proof of concept among the elements of its success as a commercial phytomedicine. [6] A Cochrane review of the extract rated the evidence as low quality for main outcomes in acute bronchitis in children and adults and very low for acute sinusitis and the common cold, and found adverse events more common with the extract, none serious. [7] So a commercial success and a trial record are two separate things. Read more at Devil's claw and Pelargonium.

Bioprospecting, consent and sharing benefits

Bioprospecting, also called biodiversity prospecting, is the seeking and documenting of traditional medical knowledge or the biodiversity it is attached to, and its conversion into a commercial product. [8] Reviewers of large programs say agreements need to address genetic access, prior informed consent, intellectual property and the sharing of benefits. [8] Critics describe cases in which patenting by corporations disregarded the ownership of knowledge held by indigenous communities. [9] The same ethnopharmacology review warns that this resource is threatened by the loss of traditional medicine knowledge and extinction of organisms. [2] See traditional knowledge protection and biopiracy and cultural appropriation and traditional healing products, where the community side is covered.

The Nagoya Protocol, in force since 12 October 2014, concerns fair and equitable sharing of benefits from genetic resources. [10] Researchers working with communities are expected to obtain educated prior informed consent before research begins. [11]

What this means for you

A drug discovered from a plant is made, tested and dosed as a medicine. Using the raw plant is not the same, and a herb may differ in content, strength and interactions. Do not replace or stop prescribed medicine on the basis of a discovery story. Ask a clinician or pharmacist about any herbal product you use. [12] For research summaries, see the therapies research and evidence.

Frequently asked questions

What is the difference between ethnobotany and ethnopharmacology?

Ethnobotany studies how people use plants. Ethnopharmacology studies traditionally used natural products and their biological activity. [1]

Are drugs really made from traditional remedies?

Some are. Artemisinin was developed after research began with traditional herbal medicine. [4]

Does a lab result on a herb mean it works?

No. Many leads fail when moved into clinical programs. [1]

What is bioprospecting?

Seeking and documenting traditional knowledge or biodiversity and converting it into a commercial product. [8]

Who should share the benefits?

Agreements often need to address consent, intellectual property and benefit sharing with the communities involved. [8]

More details: evidence, limits and cautions

The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.

A pattern, with a caution
A review of plants used as sources of drugs identified 122 compounds from 94 plant species and found that 80 percent had an ethnomedical use identical or related to the current use of the active compound. [5] That supports using traditional use as a lead. It looks at plants that already yielded drugs, so it cannot tell us how many traditional remedies fail.
References
  1. Modern drug discovery using ethnobotany: a large-scale cross-cultural analysis of traditional medicine reveals common therapeutic uses. iScience 2023. PMC10494464. Read 2026-10-22.
  2. Buenz EJ, Verpoorte R, Bauer BA. The ethnopharmacologic contribution to bioprospecting natural products. Annual Review of Pharmacology and Toxicology 2018. PubMed 29077533. Read 2026-10-22.
  3. Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. Journal of Natural Products 2020. PubMed 32162523. Read 2026-10-22.
  4. Nobel Prize Outreach. The 2015 Nobel Prize in Physiology or Medicine: press release. Read 2026-10-22.
  5. Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environmental Health Perspectives 2001. PubMed 11250806. Read 2026-10-22.
  6. Brendler T, van Wyk B-E. A historical, scientific and commercial perspective on the medicinal use of Pelargonium sidoides (Geraniaceae). Journal of Ethnopharmacology 2008. PubMed 18725280. Read 2026-10-22.
  7. Timmer A and others. Pelargonium sidoides extract for treating acute respiratory tract infections. Cochrane Database of Systematic Reviews 2013. PubMed 24146345. Read 2026-10-22.
  8. Soejarto DD and others. Ethnobotany/ethnopharmacology and mass bioprospecting: issues on intellectual property and benefit-sharing. Journal of Ethnopharmacology 2005. PubMed 15993554. Read 2026-10-22.
  9. Efferth T and others. Biopiracy of natural products and good bioprospecting practice. Phytomedicine 2016. PubMed 26926178. Read 2026-10-22.
  10. Convention on Biological Diversity. About the Nagoya Protocol. Read 2026-10-22.
  11. International Society of Ethnobiology. ISE Code of Ethics (with 2008 additions) (PDF hosted by the CBD ABS Clearing-House). Read 2026-10-22.
  12. NCCIH (US). 6 Things To Know When Selecting a Complementary Health Practitioner. Read 2026-10-22.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.